Logo image of BHC

BAUSCH HEALTH COS INC (BHC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BHC - CA0717341071 - Common Stock

5.59 USD
-0.07 (-1.24%)
Last: 1/29/2026, 8:04:00 PM
5.54 USD
-0.05 (-0.89%)
Pre-Market: 1/30/2026, 4:05:55 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BHC. BHC was compared to 190 industry peers in the Pharmaceuticals industry. While BHC is still in line with the averages on profitability rating, there are concerns on its financial health. BHC has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BHC was profitable.
  • In the past year BHC had a positive cash flow from operations.
  • BHC had negative earnings in each of the past 5 years.
  • BHC had a positive operating cash flow in 4 of the past 5 years.
BHC Yearly Net Income VS EBIT VS OCF VS FCFBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • BHC has a Return On Assets of 1.35%. This is in the better half of the industry: BHC outperforms 80.00% of its industry peers.
  • BHC's Return On Invested Capital of 7.44% is amongst the best of the industry. BHC outperforms 84.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BHC is significantly below the industry average of 12.83%.
  • The 3 year average ROIC (5.98%) for BHC is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 7.44%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.98%
ROIC(5y)5.41%
BHC Yearly ROA, ROE, ROICBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • The Profit Margin of BHC (3.61%) is better than 80.00% of its industry peers.
  • BHC has a better Operating Margin (20.68%) than 87.37% of its industry peers.
  • BHC's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 70.67%, BHC is doing good in the industry, outperforming 77.89% of the companies in the same industry.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC Yearly Profit, Operating, Gross MarginsBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

  • BHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • BHC has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BHC has been increased compared to 5 years ago.
  • BHC has a better debt/assets ratio than last year.
BHC Yearly Shares OutstandingBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC Yearly Total Debt VS Total AssetsBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • Based on the Altman-Z score of 0.24, we must say that BHC is in the distress zone and has some risk of bankruptcy.
  • BHC's Altman-Z score of 0.24 is in line compared to the rest of the industry. BHC outperforms 46.84% of its industry peers.
  • BHC has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as BHC would need 19.41 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 19.41, BHC is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.1
WACC6.78%
BHC Yearly LT Debt VS Equity VS FCFBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that BHC should not have too much problems paying its short term obligations.
  • The Current ratio of BHC (1.30) is worse than 76.84% of its industry peers.
  • A Quick Ratio of 0.97 indicates that BHC may have some problems paying its short term obligations.
  • BHC has a worse Quick ratio (0.97) than 78.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC Yearly Current Assets VS Current LiabilitesBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

  • BHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.33%.
  • Measured over the past years, BHC shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.91% on average per year.
  • BHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.86%.
  • BHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.28% yearly.
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%

3.2 Future

  • Based on estimates for the next years, BHC will show a decrease in Earnings Per Share. The EPS will decrease by -3.58% on average per year.
  • The Revenue is expected to decrease by -0.40% on average over the next years.
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 1.46 indicates a rather cheap valuation of BHC.
  • 98.95% of the companies in the same industry are more expensive than BHC, based on the Price/Earnings ratio.
  • BHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.39.
  • A Price/Forward Earnings ratio of 1.30 indicates a rather cheap valuation of BHC.
  • 98.95% of the companies in the same industry are more expensive than BHC, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.72, BHC is valued rather cheaply.
Industry RankSector Rank
PE 1.46
Fwd PE 1.3
BHC Price Earnings VS Forward Price EarningsBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BHC indicates a rather cheap valuation: BHC is cheaper than 93.68% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BHC is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.91
EV/EBITDA 6.61
BHC Per share dataBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • BHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y-1.71%

0

5. Dividend

5.1 Amount

  • No dividends for BHC!.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH HEALTH COS INC / BHC FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC) is 2 / 10.